Community Pharmacy Foundation
We are a non-profit organization dedicated to advancing community pharmacy practice and patient care delivery through grant funding and resource sharing.
Search Entire Site
Search Grants Only
Search Library Only
Like Us On Facebook!
Connect with us on LinkedIn
Like Us On Facebook!

CPF Grants
  Vision, Mission & Goals
Grant Applications
Grant Submissions Next Grant Submissions Due:
Midnight Tuesday, May 08, 2018 (Pacific Time)

The Grant Process: Discover | Apply
  Faculty | Practitioner | Residents
  Students | Others

  All CPF Grants (177)
    -  In Study (27)
    -  Completed (150)
Toolkit - NEW
Journal Publications Journal Publications
Best Practices Best Practices

  Medication Management, Safety & Quality
  Therapeutics, Diseases & Populations
  Pharmacy Management & Ownership
  Profession, Academics & Economics
  All 'Categorized' Grants
  Focus Grants

Trending Grant Topics
  Care Transitions
  All 'Trending' Grants

CPF Funds Are Available.. Learn More

First Name
Last Name

To reduce spam, enter the
security code shown below.

Get new code

Current Community Newsletter
View Our December 2017 Newsletter Online

Use of FeNO measurements in community pharmacy to improve asthma management
Principal Investigator Marvin Moore, PharmD RPh
Project Title Use of FeNO measurements in community pharmacy to improve asthma management
Grants Awarded Number 138
Status In Study
Organization University of Wisconsin- Madison School of Pharmacy
Location Madison, Wisconsin
Grant Category Therapeutics, Diseases & Populations
Keyword Asthma, FeNO
Grant Docs N/A
Objectives The goal of this study is to determine if performing fraction of exhaled nitric oxide, FeNO, testing in a community pharmacy and communicating the results to a health care provider influences decisions to change therapy in patients with asthma. FeNO is a novel measurement of airway inflammation that uses a handheld device which reports findings within minutes. FeNO measurements will provide community pharmacists with an objective measure to assess the patients asthma control and to include in the medication therapy recommendations to the health care provider. Our objectives for this study are to: 1.Measure the impact of FeNO results on health care providers decision to change prescription therapy for patients with asthma. 2.Compare pharmacist-initiated recommendations to adjust prescribed therapy based on FeNO results against the decisions made by the patients health care provider. 3.Compare decisions made by the patients health care provider based on pharmacist-provided information to an expert panel to determine if inclusion of the FeNO result should have influenced a change to the patients prescribed therapy. 4.Demonstrate the value of FeNO measurements taken at the community pharmacy to improve asthma management and encourage health plans to change billing rules to allow pharmacists to be reimbursed for FeNO testing.
The Community Pharmacy Foundation
Funding Since 2002 | Chicago Illinois
Home CPF Insider Terms Like Us On Facebook! Connect with us on LinkedIn Like Us On Facebook!
CPF Grants/Funding About Us Privacy
Pharmacy Reference Library Contact Us  
© 2018 All Rights Reserved | ISADEX Corporation | Stoughton, WI USA Community Pharmacy Foundation